Risk Factors for Accelerated Decline among Patients with Chronic Obstructive Pulmonary Disease

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 6, 1996, Pages

  Kerstjens, Huib A M ^a   Brand, Paul L P ^a   Postma, Dirkje S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CAPACITY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; REVIEW; RISK FACTOR; SURVIVAL RATE;

ADULT; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MODELS, STATISTICAL; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 0030466363     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/154.6_pt_2.s266     Document Type: Article

References (34)

1. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
2. Postma, D. S., G. H. Koëter, and P. J. Wijkstra. 1993. Course and prognosis in patients with chronic airflow obstruction: possible implications for therapy. In R. Casaburi and T. L. Petty, editors. Principles and Practice of Pulmonary Rehabilitation, 12th ed. W. B. Saunders Company, Philadelphia. 138-150.
3. Anthonisen, N. R. 1989. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am. Rev. Respir. Dis. 140:S95-S99.
4. Fletcher, C. M., R. Peto, and C. M. Tinker. 1976. The natural history of chronic bronchitis and emphysema. Oxford University Press, Oxford.
5. Barter, C. E., and A. H. Campbell. 1976. Relationship of constitutional factors and cigarette smoking to decrease in 1-second forced expiratory volume. Am. Rev. Respir. Dis. 113:305-314.
6. Campbell, A. H., C. E. Barter, J. M. O'Connell, and R. Huggins. 1985. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 40:741-748.
7. Kanner, R. E., A. D. J. Renzetti, M. R. Klauber, C. B. Smith, and C. A. Golden. 1979. Variables associated with changes in spirometry in patients with obstructive lung diseases. Am. J. Med. 67:44-50.
8. Comittee on Diagnostic Standards for Nontuberculous Respiratory Diseases. 1962. Chronic bronchitis, asthma, and pulmonary emphysema. Am. Rev. Respir. Dis. 85:762-768.
9. Postma, D. S., K. de Vries, G. H. Koëter, and H. J. Sluiter. 1986. Independent influence of reversibility of air-flow obstruction. and non-specific hyperreactivity on the long-term course of lung function in chronic airflow obstruction. Am. Rev. Respir. Dis. 134:276-280.
10. Postma, D. S., I. Peters, E. J. Steenhuis, and H. J. Sluiter. 1988. Moderately severe chronic airflow obstruction: can corticosteroids slow down obstruction? Eur. Respir. J. 1:22-26.
11. The Intemittent Positive Pressure Breathing Trial Group. 1983. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann. Intern. Med. 99:612-620.
12. Anthonisen, N. R., E. C. Wright, J. E. Hodgkin, and the IPPB Trial Group. 1986. Prognosis in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 133:14-20.
13. Burrows, B., J. W. Bloom, G. A. Traver, and M. G. Cline. 1987. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N. Engl. J. Med. 317: 1309-1314.
14. Tattersfield, A. E. 1985. Relationship of resting airway caliber to measurements of airway responsiveness in man. In F. E. Hargreave and A. J. Woolcock, editors. Airway Responsiveness: Measurement and Interpretation. Astra, Mississauga, Ontario. 94-104.
15. Orie, N. G. M., H. J. Sluiter, K. de Vries, G. J. Tammeling, and J. Witkop. 1960. The host factor in bronchitis. In N. G. M. Orie and H. J. Sluiter, editors. Bronchitis: An International Symposium. Royal Van Gorcum, Assen. 43-59.
16. Burrows, B., R. J. Knudson, A. E. Camilli, S. K. Lyle, and M. D. Lebowitz. 1987. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am. Rev. Respir. Dis. 135:788-793.
17. Brand, P. L. P., P. H. Quanjer, D. S. Postma, H. A. M. Kerstjens, G. H. Koëter, P. N. R. Dekhuijzen, H. J. Sluiter, and the Dutch CNSLD Study Group. 1992. Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax 47:429-436.
18. 1: the lung health study. J.A.M.A. 272:1497-1505.
19. Postma, D. S., and H. J. Sluiter. 1989. Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am. Rev. Respir. Dis. 140:S100-S105.
20. Kerstjens, H. A. M., P. L. P. Brand, M. D. Hughes, N. J. Robinson, D. S. Postma, H. J. Sluiter, E. R. Bleecker, P. N. R. Dekhuijzen, P. M. de Jong, H. J. J. Mengelers, S. E. Overbeek, D. F. M. E. Schoonbrood, and the Dutch CNSLD Study Group. 1992. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy in obstructive airways disease. N. Engl. J. Med. 327:1413-1419.
21. Postma, D. S., J. Burema, F. Gimeno, J. F. May, J. M. Smit, E. J. Steenhuis, L. T. van der Weele, and H. J. Sluiter. 1979. Prognosis in severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 119:357-367.
22. Hughes, J. A., D. C. S. Hutchison, D. Bellamy, D. E. Dowd, K. C. Ryan, and P. Hugh-Jones. 1982. The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema. Q. J. Med. 202:115-124.
23. Leuenberger, P., J. Schwartz, U. Ackermann-Liebrich, K. Blaser, G. Bolognini, J. P. Bongard, O. Brandli, P. Braun, C. Bron, M. Brutsche, G. Domenighetti, S. Elsasser, P. Guldimann, C. Hollenstein, P. Hufschmid, W. Karrer, R. Keller, H. Keller-Wossidlo, N. Kunzli, J. C. Luthi, B. W. Martin, T. Medici, A. Perruchoud, A. Radaelli, C. Schindler, M. H. Schoeni, G. Solari, J. M. Tschopp, B. Villager, B. Wuthrich, J. P. Zellweger, and E. Zempt. 1994. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA study). Am. J. Respir. Crit. Care Med. 150:1222-1228.
24. Xu, X., and B. Li. 1995. Exposure-response relationship between passive smoking and adult pulmonary function. Am. J. Respir. Crit. Care Med. 151:41-46.
25. Nocturnal Oxygen Therapy Trial Group. 1980. Continous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med. 93:391-398.
26. Medical Research Council Working Party. 1981. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet i:681-686.
27. Strom, K., 1993. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am. Rev. Respir. Dis. 147:585-591.
28. Postma, D. S., E. J. Steenhuis, L. T. van der Weele, and H. J. Sluiter. 1985. Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur. J. Respir. Dis. 67:56-64.
29. Dompeling, E., C. P. van Schayck, P. M. van Grunsven, C. L. A. van Herwaarden, R. Akkermans, J. Molema, H. Folgering, and C. van Weel. 1993. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a 4 year prospective study. Ann. Intern. Med. 118:770-778.
30. 1 during long-term inhaled corticosteroid treatment. Eur. Respir. J. 6:868-876.
31. Pauwels, R. A., C. G. Lofdahl, N. B. Pride, D. S. Postma, L. A. Laitinen, and S. V. Ohlsson. 1992. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur. Respir. J. 5:1254-1261.
32. Burge, P. S., and P. Calverly. 1994. Inhaled steroids in obstructive lung disease in Europe, the ISOLDE trial: protocol and progress (abstract). Am. J. Respir. Crit. Care Med. 149:A312.
33. van Schayck, C. P., E. Dompeling, C. L. A. van Herwaarden, H. Folgering, A. L. M. Verbeek, H. J. M. van den Hoogen, and C. van Weel. 1991. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. B.M.J. 303:1426-1431.
34. Sherrill, D. L., M. D. Lebowitz, R. J. Knudson, and B. Burrows. 1991. Smoking and symptom effects on the curves of lung function growth and decline. Am. Rev. Respir. Dis. 144:17-22.